An example of this includes genome-wide CRISPR knockout screens in MSI colorectal cancers that pinpointed the WRN helicase as a synthetic-lethal vulnerability, prompting the preclinical development of WRN inhibitors [61,62,63]. Here, WRN is linked to colorectal cancer.